News Industry steps up as EU debates an action plan for AI Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.
News Share in cystic fibrosis firm Sionna rise sharply after IPO Sionna has closed its IPO, raising $191m for cystic fibrosis candidates that it thinks could be more effective than rivals from Vertex.
News NIH indirect funding cuts appals medical research groups Billions of dollars will be cut from medical research funding provided by the NIH in the latest money-saving programme from the Trump administration.
News MSD starts pivotal trial of ROR1 drug in first-line lymphoma MSD has started a phase 3 trial of ROR1-directed ADC zilo-V as a treatment for previously untreated diffuse large B-cell lymphoma.
News Novo charts course ahead for CagriSema after lacklustre data After its first phase 3 trial of obesity hope CagriSema left investors dissatisfied, Novo Nordisk has a plan to get the programme back on track.
News RFK Jr odds on for HHS role after Finance Committee vote Robert F Kennedy Jr has cleared a key obstacle in his bid to become the next HHS Secretary after the Senate Finance Committee voted in his favour.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.